Resvita Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
Resvita Bio General Information
Description
Developer of a synthetic biology platform intended to create innovative treatments for skin diseases. The company uses genetically engineered bacteria to produce and deliver therapeutic proteins directly to affected areas, with continuous treatment without the limitations of traditional therapies, enabling patients to target conditions such as Netherton Syndrome and Severe Atopic Dermatitis, offering a potentially transformative method for managing skin disorders.
Contact Information
Website
www.resvitabio.comCorporate Office
- 2625 Durant Avenue
- Berkeley, CA 94720
- United States
Corporate Office
- 2625 Durant Avenue
- Berkeley, CA 94720
- United States
Resvita Bio Timeline
Resvita Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 7. Grant | 24-Sep-2024 | Completed | Generating Revenue | |||
| 6. Seed Round | 06-Dec-2023 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jul-2023 | Completed | Generating Revenue | |||
| 4. Grant | 20-Sep-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 06-May-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2021 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Resvita Bio Patents
Resvita Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4719461-A1 | Methods of treating skin conditions using genetically engineered microorganisms | Pending | 25-May-2023 | ||
| WO-2024243532-A1 | Methods of treating skin conditions using genetically engineered microorganisms | Inactive | 25-May-2023 |
Resvita Bio Signals
Resvita Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| California Life Sciences | Accelerator/Incubator | |||
| Berkeley Frontier Fund | Venture Capital | Minority | ||
| California Innovation Fund | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Resvita Bio FAQs
-
When was Resvita Bio founded?
Resvita Bio was founded in 2021.
-
Where is Resvita Bio headquartered?
Resvita Bio is headquartered in Berkeley, CA.
-
What is the size of Resvita Bio?
Resvita Bio has 9 total employees.
-
What industry is Resvita Bio in?
Resvita Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Resvita Bio a private or public company?
Resvita Bio is a Private company.
-
What is Resvita Bio’s current revenue?
The current revenue for Resvita Bio is .
-
Who are Resvita Bio’s investors?
California Life Sciences, Berkeley Frontier Fund, California Innovation Fund, Gaingels, and are 5 of 11 investors who have invested in Resvita Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process